Melanoma immunotherapy research at UCLA

€165700 55.23%
admin August 23, 2021 Donors: 11
  • €165700
    of €300000

News: the team is making amazing progress!

The Alan Ghitis Association has already funded phase 1 of the project, with great results. Our fundraising campaign continues for phase 2 and the clinical trial.

Melanoma research at the Jonsson Cancer Center of UCLA

Prof. Antoni Ribas’s team is making amazing progress! Pfizer is now using the research developed by the team.

In phase one of the project:

We have provided funds to a researcher in his laboratory and they made a fantastic discovery : removing PAK4 protein from cancer cells helps to bring T cells into the tumor to make the patient respond to immunotherapy.

Part of the funds allocated to phase 1 of the project were enabled by a private donation by Bill Ghitis before our association was set up.

The research headed by UCLA’s Dr. Antoni Ribas and the researcher Gabriel Abril-Rodriguez has been focusing on overcoming resistance to immunotherapy

If you want to know more, click on the links to read some articles published about this project :

In phase two of the project:

Those laboratory-based findings are already being tested in the clinic. The more we understand how PAK4 inhibition works, the easier it is to translate this science into a new drug that helps patients with cancer. The team needs more funds to achieve this!

  • €165700 Raised
    of €300000
 
Or donate from US website